Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Catherine Milne

Nurse Practitioner Plymouth, CT Nurse Practitioner

NPI 1659336303 CMS profile 10448551

204 Keegan Rd, Plymouth, CT 06782

Open in the dashboard

General payments

$361,358

453 records reported · program years 2021–2025

Research payments

$1,250

Paid to them · 2 records reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Catherine Milne of Plymouth, CT is reported in the CMS Open Payments database as having received $361,358 across 453 general payments and $1,250 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Nurse Practitioner profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $87,133 100
2025 Research $1,250 2
2024 General $94,618 113
2023 General $68,630 101
2022 General $74,720 81
2021 General $36,257 58

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Catherine Milne
  • Nurse Practitioner median
  • Middle half of Nurse Practitioner
  • National median

In program year 2025, general payments to Catherine Milne were reported at $87,133. Among 41,044 Nurse Practitioner profiles paid that year, the median was $174 and the middle half received between $55 and $557.

Show as a table
Year Catherine Milne Nurse Practitioner median Middle half National median
2019 $0 $50 $22–$97 $163
2020 $0 $40 $16–$108 $114
2021 $36,257 $135 $40–$426 $132
2022 $74,720 $152 $48–$470 $149
2023 $68,630 $166 $54–$529 $160
2024 $94,618 $173 $55–$556 $164
2025 $87,133 $174 $55–$557 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. KCI USA, Inc $97,578 128 payments
  2. ConvaTec Inc. $87,858 98 payments
  3. Smith+Nephew, Inc. $66,748 69 payments
  4. Solventum Corporation $50,860 66 payments
  5. Medline Industries, Inc. $30,705 47 payments
  6. Aroa Biosurgery Incorporated $13,671 15 payments
  7. Sanara MedTech Inc. $6,461 8 payments
  8. Hartmann USA, Inc. $6,041 13 payments
  9. MIMEDX Group, Inc. $979 5 payments
  10. Owens & Minor Distribution, Inc. $189 1 payment
  11. Other $269 3 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Consulting Fee $139,382 113 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $111,929 70 payments
  3. Travel and Lodging $87,071 135 payments
  4. Food and Beverage $10,944 130 payments
  5. Education $10,006 4 payments
  6. Compensation for serving as faculty or as a speaker for a medical education program $2,025 1 payment
Products named General payments · program years 2021–2025
  1. PROMOGRAN PRISMA $68,755 87 payments
  2. NATURA+ $58,901 64 payments
  3. ACTIV.A.C. $56,855 64 payments
  4. V.A.C. DERMATAC $43,368 58 payments
  5. 3M Cavilon $40,522 36 payments
  6. PICO $36,339 15 payments
  7. 3M Coban $35,622 43 payments
  8. KerraMax Care $31,907 42 payments
  9. V.A.C. VERAFLO $25,892 28 payments
  10. SNAP $25,749 28 payments
  11. Other $374,765 398 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2021–2025
  1. Kerecis Limited $1,250 2 payments

Billing to Medicare

Part B · data year 2024 · 18 billing codes

Paid by Medicare

$68,338

Medicare's payments for the services billed

Medicare patients

469

Average age 82

Services billed

1,613

274 women, 195 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 58%
Depression 55%
Alzheimer's or dementia 52%
Heart failure 50%
Chronic kidney disease 48%
Ischemic heart disease 45%
Diabetes 43%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

455 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner in Connecticut

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record